MTOR and systemic lupus erythematosus: mTOR activation triggers ROS production, and SIRT2 regulates the expression of IL-17A in these cells by regulating the mTORC1/HIF-1α/RORγt signaling pathway, thus participating in the pathogenesis of SLE.